MAP1LC3B and Parkinson disease: Therefore, our results should be interpreted with caution, and further studies with strict protocols for data acquisition, CSF handling, and delicate adjustments of confounding factors are needed, although we confirmed that LC3B displayed a higher sensitivity and specificity for the diagnosis of PD compared to α-synuclein and total tau levels.